Studies of tumor neovasculature have revealed silencing of the tumor suppressor von Hippel-Lindau (VHL) gene or loss of chromosome 3p, causing activation of hypoxia-inducible transcription factor, and further production of proangiogenic growth factors, such as vascular endothelial growth factor (VEGF) [4,5]. The gene discussed is VEGFA; the disease is neoplasm.